Note 19 - Segment Reporting - Schedule of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Net revenue	$ 17,993	$ 22,733	$ 63,026	$ 76,667
Income (loss) from operations	(2,464)	(8,558)	(1,604)	(17,234)
Depreciation and amortization	1,834	1,843	5,674	5,551
Stock-based compensation expense	811	902	2,561	5,146
Impairment expense	0	0	0	2,600
Rx Segment [Member]
Net revenue	14,025	13,805	50,590	50,486
Income (loss) from operations	(1,598)	(7,122)	682	(13,579)
Depreciation and amortization	1,449	1,563	4,513	4,709
Stock-based compensation expense	699	788	2,131	4,937
Impairment expense				2,600
Consumer Health [Member]
Net revenue	3,968	8,928	12,436	26,181
Income (loss) from operations	(866)	(1,436)	(2,286)	(3,655)
Depreciation and amortization	385	280	1,161	842
Stock-based compensation expense	$ 112	$ 114	$ 430	209
Impairment expense				$ 0